Professor Lawrence Leiter
University of Toronto, Toronto (Canada)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
A cross-specialty focus – Who are the appropriate patients for SGLT2is?
Event: ESC Congress 2019
Topic: Cardiovascular Disease in Special Populations
Session type: Satellite Symposium - Experts on the Spot
Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?
Event: ESC Congress 2019
Topic: Cardiovascular Disease in Special Populations
Session type: Satellite Symposium
GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?
Event: ESC Congress 2019
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
Event: ESC Congress 2018
Topic: Pharmacology and Pharmacotherapy
Session type: Satellite Symposium - Experts on the Spot
Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes
Event: ESC Congress 2016
Topic: Diabetes management
Session type: Satellite Symposium
ESC 365 is supported by
